Diabetes Education Is The Key Driver To Thailand’s SMBG Market, Finds Frost & Sullivan

Stronger diabetes education and awareness leads to increase market growth for Thailand's SMBG devices market
 
Dec. 12, 2010 - PRLog -- The increasing rate of obesity caused by poor lifestyle habits and large consumption of food that is high in sugar content have been one of the major contributory factors towards  the rise of diabetes in Thailand. Other factors include a low diagnosed rate of diabetes in Thailand.

This is most common in rural provinces where villagers self-diagnose diabetes by observing the presence and behavior of ants’ surrounding the lavatory, which might be too late for the patient as the disease is likely to have reached chronic stage.

Religious influence from Buddhism also plays an integral role in Thailand’s rise in diabetes as Buddhist teachings consider illness as part of the natural human lifecycle; therefore continuous monitoring and prevention from further deterioration of diseases is perceived as unnecessary.

Frost & Sullivan latest research reveals that Thailand’s diabetes prevalence rate is reaching near double digits at 9.6 percent with incidence rates of 4.8 percent in 2009. Jennifer Lau, Industry Analyst, Frost & Sullivan commented that self-monitoring blood glucose (SMBG) and strips devices are paramount to the management of diabetes in Thailand.

“Thailand’s public health service has become instrumental in driving the adoption of SMBG devices. Under the ‘30-Baht Health Reform’, more patients are now able to seek treatment and better blood glucose management” comments Lau.

In 2007, Thailand’s total market size for SMBG devices and strips was only valued at USD 15million. However, with the awareness campaign launched over the last few years by Thai authorities, the market has achieved revenues up to USD 45million in 2009, recording more than a 60 percent increase over the period of 2 years.

The SMBG devices market consumption is divided into two segments - retail and hospitals. Currently, hospital users are consuming only strips with 49 percent of the revenue contributed by this segment group. Hospitals need not purchase the device (glucose meters) as these are mostly given without charge when hospitals purchase strips in bulk. On the other hand, direct retail to patients generated 51% of the revenue for both strips and meters SMBG devices in 2009.

“In order for change in adoption patterns to emerge, the private and public sectors must work together to implement change” states Lau.

The biggest driver for the adoption of SMBG devices in the market is the continuous education given by suppliers to diabetes nurses, allowing these nurses to be more proactive in educating their patients and the public, thereby increasing their awareness about diabetes. The SMBG manufacturers are also directly educating the patients on the importance of continuous monitoring of blood glucose and this has added to the growth of the industry in Thailand.

The Thai government has also ramped up their awareness campaign by offering frequent health screening for diabetes at local community medical institutions. The government has also established initiatives to reach out to rural provinces by actively participating with the rest of the world in recognizing 12th November 2009 as ‘World Diabetes Day’ and conducting additional screenings and educational activities about diabetes at rural medical centers.

While most campaigns are directly related to diabetes, government campaigns such as “Khon Thai Rai Pung” indirectly impacts the industry by raising awareness amongst the population of the dangers of obesity leading to diabetes. This campaign prompts citizens to participate in health screening, thus further boosts the diagnosed rate, which in turn, will drive the growth of the SMBG market.

With proper management and detection of new diabetes cases per year, Frost & Sullivan’s research indicates that the SMBG devices market in Thailand will soon reach USD 141million in revenue by 2016 with compound annual growth rate (CAGR) of 17.5 percent from 2009 – 2016.

“Diabetes is a lifestyle disease that is not easily treated, but if managed properly, patients can greatly improve their quality of life even when inflicted with the disease. However, it starts with constant monitoring” concludes Lau.

MEDIA CONTACT:

Donna Jeremiah
Corporate Communications – Asia Pacific
P: +603 6204 5832
F: +603 6201 7402
E: djeremiah@frost.com

Nicklaus Au
Corporate Communications – Asia Pacific
P: +603 6204 5836
F: +603 6201 7402
E: nicklaus.au@frost.com

# # #

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.
End
Source: » Follow
Email:***@frost.com Email Verified
Tags:Healthcare, Diabetes, Pharmaceutical, Smbg, Frost & Sullivan, Medical Device, Glucose, Blood Monitoring
Industry:Education, Health
Location:Malaysia
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Frost & Sullivan News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share